| Sales | |
| Cost of goods sold | -34.42M |
| Gross profit | 45.34M |
| Operating expenses: | |
| Sales and marketing expenses | -30.5M |
| General and administrative expenses | -5.25M |
| Loss on disposal of biological assets | |
| Total operating expenses | -35.75M |
| Other operating income, net | 158.26K |
| Operating income (loss) | 9.74M |
| Other income (expenses): | |
| Interest income | |
| Interest and finance costs | -828.94K |
| Amortization of deferred debt issuance cost | |
| Government subsidy | |
| Income (loss) before income taxes | |
| Income tax (expenses) benefits | -3.55M |
| Net income (loss) | 10.56M |
| Net (loss) income attributable to noncontrolling interests | 0 |
| Net income (loss) attributable to common shareholders of Feihe International, Inc. | 10.56M |
| Net income (loss) per share of common stock | |
| Basic | |
| Diluted | |
| Weighted average shares used in calculating net income (loss) per share of common stock | |
| Basic | 19.78M |
| Diluted | 19.78M |
| Temporary Equity | |
| Net income (loss) per share of common stock | |
| Basic | |
| Diluted | |
| Weighted average shares used in calculating net income (loss) per share of common stock | |
| Basic | 19.78M |
| Diluted | 19.78M |